Steve Allen has enjoyed a 30-year career with a track record of building a wide range of Life Science product and service companies, from start-ups to multinational corporations. Before his most recent role as CEO of DNAe, Steve held a number of leadership positions at PerkinElmer, Mettler-Toledo and LGC Forensics. Having led the acquisition of over 15 companies and the successful launch of more than fifty new scientific products and services, Steve has used his experience to assist early stage companies to make the step change from scientific innovation to commercial success. This includes the Next Generation Sequencing pioneer Solexa, where he was a Non-Executive Director and consultant, helping to scale the company to product launch and sale to Illumina. Steve has a PhD in Chemistry from the University of Nottingham.